Clinical Trials
If you are interested in participating in our research, give us a call at (503)-207-2066 to determine your eligibility.
Current Clinical Research Projects at our Clinic
TauRx Therapeutics Ltd. (LUCIDITY)
Protocol: TRx-237-039
Patients: <90 years old
Diagnostic: MCI/Early Alzheimer’s disease
Agent: Leuco-methylthioninium bis(hydromethanesulfonate) (LMTM)
Daily Oral Administration
Currently Enrolling: No
Athira Pharma Inc. (Act AD)
Protocol: ATH-1017-AD-0202
Patients: 55-85 years old
Diagnostic: Probable Mild-Moderate AD
Agent: ATH-1017
Daily Subcutaneous Injection
Currently Enrolling: Yes
Eli Lilly and Company (TRAILBLAZER-ALZ2)
Protocol: I5T-MC-AACI
Patients: 60-85 years old
Diagnostic: Prodromal AD or Mild AD Dementia
Agent: Donanemab
Intravenous Administration Every 4 Weeks
Currently Enrolling: No
Alzheon Inc. (APOLLOE4)
Protocol: ALZ-801-AD301
Patients: 50-80 years old
Diagnostic: Early Alzheimer’s disease
Agent: ALZ-801
Twice Daily Oral Administration
Currently Enrolling: No
Eisai (Clarity AD)
Protocol: BAN2401-G000-301
Patients: 50-90 years old
Diagnostic: MCI due to AD/Mild AD
Agent: Monoclonal anti-amyloid antibody
Infusion
Currently Enrolling: No